Description
The Worldwide Microbiology Market (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology)
Microbiology has always been a major segment of the diagnostic market because the burden of infectious diseases is high. This important field is attracting even more attention today as the because of the large and growing problem of antibiotic resistance. The Worldwide Microbiology Market provides current market (2017) and market projections (to 2022) by segment (traditional microbiology, microbiology/infectious disease immunoassays, molecular microbiology, mass spectrometry in microbiology, total microbiology market), by pathogen/disease (healthcare-acquired infections / antimicrobial resistance, STDs / women’s health, hepatitis, HIV, respiratory tract infections, others), and by geographic region (North America, Western Europe, Japan, China, India, Latin America (incl. Mexico), rest of the world).
The report also looks at the global microbiology/infectious disease immunoassay 2017-2022 market by segment (laboratory-based immunoassays, rapid/point-of-care immunoassays, total microbiology/infectious disease immunoassay market), by geographic region (North America, Western Europe, Japan, China, India, Latin America (incl. Mexico), rest of the world), and by pathogen/disease indication (hepatitis, HIV, STDs, TORCH, respiratory, sepsis, parasitology, mycology, others).
There is a need for rapid tests that can quickly identify a microbial pathogen, and (if the pathogen is a bacteria) identify what antibiotic will be effective in treating the infection – all before a physician makes the treatment decision. This ideal test does not yet exist, but considerable advances are occurring in fields such as molecular microbiology and mass spectrometry in the microbiology laboratory. In addition, new technologies and platforms are being developed by companies that are working towards development of this much needed test. Beckman Coulter, Becton Dickinson, bioMérieux, and Thermo Fisher Scientific are among the market companies profiled in the report.91
Table of Contents
CHAPTER 1: EXECUTIVE SUMMARY
OVERVIEW
SCOPE AND METHODOLOGY
MARKET OVERVIEW
Table 1-1: Worldwide Microbiology Market, by Segment, 2017-2022 (in millions USD) (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology, Total Microbiology Market)
CHAPTER 2: INTRODUCTION
THE MICROBIOLOGY LABORATORY
TRADITIONAL MICROBIOLOGY – MICROBIAL IDENTIFICATION AND ANTIBIOTIC SUSCEPTIBILITY TESTING (ID/AST)
ADVANCES IN MICROBIOLOGY
THE QUEST FOR RAPID MICROBIAL IDENTIFICATION/ANTIBIOTIC SUSCEPTIBILITY (RESISTANCE) TESTS
Figure 2-1: Moving Towards the Goal of Rapid Microbial Identification and Antibiotic Resistance/Susceptibility Testing – Evolution towards a Platform that Combines Desired Characteristics of Different Technologies
Point-of-View and Methodology
CHAPTER 3: WHY CARE ABOUT WHAT IS HAPPENING IN MICROBIOLOGY? INFECTIOUS DISEASE TRENDS
BURDEN OF INFECTIOUS DISEASE
EMERGING THREATS
THE PROBLEM OF MICROBIAL ANTIBIOTIC RESISTANCE
LIMITATIONS OF TRADITIONAL MICROBIOLOGY
NEEDED: RAPID MICROBIAL IDENTIFICATION AND ANTIBIOTIC SUSCEPTIBILITY/RESISTANCE TESTS
CHAPTER 4: SELECTED TECHNOLOGIES/PLATFORMS IN MICROBIOLOGY LABORATORIES
TRADITIONAL MICROBIOLOGY
Overview of Traditional Microbial ID/AST
Table 4-1: Microbiology Sample/Specimen Types Ranked by Average Volume
ID/AST Systems, and Panels and Reagents for ID/AST Systems
Table 4-2: Major Companies Marketing Microbial ID/AST Systems
Chromogenic Media
Table 4-3: Selected Companies Marketing Chromogenic Media
Rapid Tests Performed on Colonies from Culture Media
Blood Culture
Table 4-4: Selected Companies Marketing Blood Culture Systems
MASS SPECTROMETRY
Table 4-5: Mass Spectrometry Companies in Microbiology
IMMUNOASSAYS
Traditional Rapid Immunoassay Technologies – Flow Through Assays and Immunochromatographic (Lateral Flow) Tests
Enzyme Immunoassays
POLYMERASE CHAIN REACTION AND OTHER NUCLEIC ACID AMPLIFICATION TECHNOLOGIES
Table 4-6: Selected Nucleic Acid Amplification Test and Other Molecular Companies in Microbiology
CHAPTER 5: ADVANCES IN THE MICROBIOLOGY LABORATORY
LIQUID MICROBIOLOGY AND ID/AST AUTOMATION
ADVANCES IN MICROBIAL IDENTIFICATION FOLLOWING BLOOD CULTURE
MASS SPECTROMETRY
PCR AND OTHER NAAT BASED TESTS FOR INFECTIOUS DISEASES
NEXT GENERATION SEQUENCING
Table 5-1: Selected Companies Applying DNA/RNA Sequencing to Microbiology
CHAPTER 6: APPLICATIONS AND ADVANCES IN MOLECULAR MICROBIOLOGY
APPLICATIONS OF MOLECULAR TESTING IN THE MICROBIOLOGY LABORATORY – SELECTED EXAMPLES
Sexually Transmitted Diseases and Women’s Health
Hepatitis
HIV
Hospital-Acquired Infections (HAIs)
Respiratory Infections
Tuberculosis
MULTIPLEX TESTS AND SYNDROMIC TESTING
What is Syndromic Testing and Why is ii Important?
When Should Syndromic Testing Be Performed? Syndromic Testing versus Traditional Single or Duplex Multiple Diagnostic Tests
DNA AND RNA SEQUENCING IN MICROBIOLOGY
CHAPTER 7: RAPID MICROBIOLOGY
“RAPID” TESTING IN MICROBIOLOGY LABS TODAY – FASTER THAN TRADITIONAL MICROBIOLOGY, BUT…
MAKING PROGRESS – DEVELOPMENT OF FASTER IDENTIFICATION AND ANTIMICROBIAL SUSCEPTIBILITY/RESISTANCE TESTS FOR THE MICROBIOLOGY LAB AND NEAR PATIENT OR POINT-OF-CARE
Table 7-1: Selected Companies Developing Faster Identification, Some Also with Antimicrobial Susceptibility/Resistance Tests
CHAPTER 8: CORPORATE DEALS IN MICROBIOLOGY
INVESTMENTS AND FINANCING AGREEMENTS
Table 8-1: Selected Investment and Financing Agreements in Microbiology
MERGER AND ACQUISITIONS
Table 8-2: Selected Acquisitions of Microbiology Companies
CORPORATE AGREEMENTS AND COLLABORATIONS
Table 8-3: Selected Agreements between Microbiology Companies and Other Companies
MICROBIOLOGY COMPANY COLLABORATIONS AND OTHER AGREEMENTS WITH UNIVERSITIES, NON-PROFIT RESEARCH INSTITUTES AND GOVERNMENT
Table 8-4: Selected Microbiology Company Agreements with Academia or Other Non-Profit Organizations
CHAPTER 9: MARKET DRIVERS, CHALLENGES, AND TRENDS IN MICROBIOLOGY
COST OF MOLECULAR MICROBIOLOGY TESTS VERSUS TRADITIONAL MICROBIOLOGY
CLINICAL MARKET DRIVERS
NEAR-PATIENT AND POINT-OF-CARE TESTING MARKET DRIVERS AND CHALLENGES/HURDLES
COMPETITION
REGULATION
REIMBURSEMENT
FUTURE PROSPECTS
CHAPTER 10: MICROBIOLOGY MARKET ANALYSIS
WORLDWIDE MICROBIOLOGY MARKET
Table 10-1: Worldwide Microbiology Market, by Segment, 2017-2022 (in millions USD) (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology, Total Microbiology Market)
Table 10-2: Major Pathogens/Disease Indications in Microbiology/Infectious Disease Market, 2017 (%) (Healthcare-Acquired Infections / Antimicrobial Resistance, STDs / Women’s Health, Hepatitis, HIV, Respiratory Tract Infections, Others)
Table 10-3: Worldwide Microbiology Market, by Geographic Region, 2017-2022 (in millions USD) (North America, Western Europe, Japan, China, India, Latin America, Rest of the World, Total Microbiology Market)
TRADITIONAL MICROBIOLOGY ID/AST MARKET
Microbial Identification and Antimicrobial Susceptibility Systems
Blood Culture
Chromogenic Media
Rapid Tests Performed on Colonies from Culture Media
Table 10-4: Worldwide Traditional Microbiology Market, by Segment, 2017-2022 (in millions USD) (Automated ID/AST Systems, Manual ID/AST Systems, Blood Culture, Chromogenic Media, Rapid Microbiology, Total Traditional Microbiology Market)
Table 10-5: Worldwide Traditional Microbiology Market, by Geographic Region, 2017-2022 (in millions USD) (North America, Western Europe, Japan, China, India, Latin America (incl. Mexico), Rest of the World, Total Traditional Microbiology Market)
Table 10-6: Market Shares of Selected Companies in the Traditional Microbiology Market (%)
MICROBIOLOGY/INFECTIOUS DISEASE IMMUNOASSAY MARKET
Table 10-7: Worldwide Microbiology/Infectious Disease Immunoassay Market, by Segment, 2017-2022 (in millions USD) (Laboratory-Based Immunoassays, Rapid/Point-of-Care Immunoassays, Total Microbiology/Infectious Disease Immunoassay Market)
Table 10-8: Worldwide Microbiology/Infectious Disease Immunoassay Market, by Geographic Region, 2017-2022 (in millions USD) (North America, Western Europe, Japan, China, India, Latin America (incl. Mexico), Rest of the World, Total Microbiology/Infectious Disease Immunoassay Market)
Table 10-9: Worldwide Clinical Laboratory-Based Microbiology/Infectious Disease Immunoassay Market, by Pathogen/Disease Indication, 2017 (in millions USD) (Hepatitis, HIV, STDs, TORCH, Respiratory, Sepsis, Parasitology, Mycology, Others [includes immunoassays for EBV, Chagas, Dengue, Malaria, etc.], Total)
Table 10-10: Worldwide Rapid Microbiology/Infectious Disease Immunoassay Market, by Pathogen/Disease Indication, 2017 (in millions USD) (Influenza, HIV, Malaria, Hepatitis, STDs [includes Chlamydia and syphilis], C. difficile, E. coli, Strep A, H. pylori, Home Test / OTC, Others, Total)
MOLECULAR MICROBIOLOGY MARKET
Table 10-11: Worldwide Molecular Microbiology Market, by Pathogen/Disease Indication, 2017-2022 (in millions USD) (Hepatitis, HIV, Healthcare Acquired Infections and Sepsis, Respiratory Pathogens, Sexually Transmitted Diseases and Women’s Health, Tuberculosis, Other, Total Worldwide Molecular Microbiology Market)
Table 10-12: Worldwide Molecular Microbiology Market, by Geographic Region, 2017-2022 (in millions USD) (North America, Western Europe, Japan, China, India, Latin America, Rest of the World, Total – World Molecular Microbiology Market)
Table 10-13: Major Company Market Shares in Molecular Microbiology Diagnostic Testing (%)
MICROBIOLOGY MASS SPECTROMETRY MARKET
Table 10-14: Worldwide Microbiology Mass Spectrometry Market, 2017-2022 (in millions USD)
FUTURE MARKET POTENTIAL FOR RAPID MICROBIAL IDENTIFICATION AND ANTIBIOTIC SUSCEPTIBILITY/RESISTANCE TESTS
CHAPTER 11: COMPANY PROFILES
3I DIAGNOSTICS, INC. (3IDX)
ABBOTT
Recent Revenue History
Table 11-1: Abbott Revenues (2014 – 2016, plus first 9 months of 2017) (millions USD)
Company Overview – With a Focus on Microbiology/Infectious Disease Diagnostics
ACCELERATE DIAGNOSTICS, INC.
Recent Revenue History
Table 11-2: Accelerate Diagnostics, Inc. (2014 – 2017) (thousands USD)
Company Overview
ATLAS GENETICS LTD.
AUTOGENOMICS, INC.
BECKMAN COULTER, INC. (A DANAHER CORPORATION COMPANY)
Revenue History
Company Overview
BECTON, DICKINSON AND COMPANY (BD)
Recent Revenue History
Table 11-3: Becton, Dickinson and Co. Revenues (FY2015 to FY2017) (millions USD)
Company Overview
BIO-RAD LABORATORIES, INC
Recent Revenue History
Table 11-4: Company Revenues (2014 – 2017) (thousands USD)
Company Overview
BIOFIRE DIAGNOSTICS, LLC. (ACQUIRED BY BIOMÉRIEUX)
Recent Revenue History and Other Financial Information
Company Overview
BIOMÉRIEUX SA
Recent Revenue History
Table 11-5: bioMérieux Revenues (2015-2017) (millions euros)
Company Overview
BRUKER CORPORATION
Recent Revenue History
Table 11-6: Bruker Corporation Revenues (2014 – 2017) (millions USD)
Company Overview:
CEPHEID (A DANAHER COMPANY)
Recent Revenue History
Table 11-7: Company Revenues (2013 – 2015, last year available) (thousands USD)
Company Overview
COPAN ITALIA S.P.A. AND COPAN DIAGNOSTICS, INC.
CURETIS
Recent Revenue History
Table 11-8: Curetis N.V. Revenues (2015 – 2017)
Company Overview
DIASORIN S.P.A.
Recent Revenue History
Table 11-9: DiaSorin Revenues (2015 – 2016, plus first nine months of 2017) (millions of euros)
Company Overview
ELITECH GROUP
GENEPOC INC.
GENMARK DIAGNOSTICS, INC.
Recent Revenue History
Table 11-10: GenMark Diagnostics Revenues (2014 – 2017) (thousands USD)
Company Overview
HOLOGIC, INC.
Recent Revenue History
Table 11-11: Hologic, Inc. Revenues (FY2015 – FY2017) (millions USD)
Company Overview
JANSSEN DIAGNOSTICS (JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON)
LUMINEX CORPORATION
Recent Revenue History
Table 11-12: Luminex Corporation Revenues (2014 – 2017) (thousands USD)
Company Overview
MAST GROUP
Q-LINEA AB
QIAGEN N.V.
Recent Revenue History
Table 11-13: Company Revenues (2015-2017) (thousands USD)
Company Overview
QUANDX INC.
QUANTUMDX GROUP
QUIDEL, INC.
Recent Revenue History
Table 11-14: Quidel Revenues (2015-2017) (thousands USD)
Company Overview
QVELLA CORPORATION
RHEONIX, INC.
ROCHE
Recent Revenue History
Table 11-15: Roche Revenues (2015-2017) (millions USD)
Company Overview
SIEMENS HEALTHINEERS
Recent Revenue History
Siemens Revenues (2016 – 2017) (millions euros)
Company Overview
THERMO FISHER SCIENTIFIC INC.
Recent Revenue History
Table 11-16: Thermo Fisher Scientific (2015-2017) (millions USD)
Company Overview
XAGENIC INC
